The fact that the Clinical Research Site Awards granted to emovis has not been fully recognized by everyone demonstrates the modesty and/or the focus of the emovis study site team. An award. Great! What exactly does it mean? Hmm. The opportunity to inquire at INC Research directly arose within the framework of the DIA 2017. The result: outstanding.
INC Research collaborates with more than 10,000 sites worldwide. Only 50 each are recognized for outstanding performance in spring and fall. In summary (status June 2017), only 364 sites received the award.
Opinions of the clinical monitors on the evaluation process are decisive. Based on these opinions it is determined why a site has earned the award, and/or in which way the site provides excellent support to the monitors and enables the success of the project. In the case of emovis it had to be the "Alkermes" project, which is also a Best Case for the team, regardless of the award.
The nice award, a tasteful transparent plaque engraved on dark background has now received a place of honor at emovis; in the CRA office on the first floor. Next to the awards granted by Pfizer, PAREXEL und Quintiles. emovis strives everyday, to justify the "Hall of Fame" and to consistently increase it.
The membership at SCRS has been awarded as a brownie point in addition to the Clinical Research Site Award. emovis also appreciates this gesture very much.